Option Care Health (OPCH) fundamentals: P/E, valuation, undervalued?

Option Care Health · Health Care · ref. ETF XLV · price $31.1
Logo Option Care HealthSee the full Option Care Health (OPCH) profile
In short — Option Care Health trades at 23.6× earnings (P/E), 14.9× forward, with a net margin of 3.7 % and revenue growth of +2 %. Read: Fairly valued (P/E 15 in line with ~13% growth (PEG 1.2)).

Is Option Care Health stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.

📈 1-year price
$31.1+14.8% over range
Oct 14, 25low $19.52 · high $36.59Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
9% recommend buying · 11 analysts
Valuation : Fairly valued — P/E 15 in line with ~13% growth (PEG 1.2)

Valuation

23.6
P/E (price/earnings)
14.9
Forward P/E
1.83
PEG
3.7
Price/book (P/B)
$4.7B
Market cap
1.32
EPS

Profitability & growth

3.7 %
Net margin
+2 %
Revenue growth
+13 %
Earnings growth
$1.3B
Total debt

Option Care Health income statement

Fiscal yearRevenueNet incomeMargin
2022$3.9B$151M3.8 %
2023$4.3B$267M6.2 %
2024$5.0B$212M4.2 %
2025$5.6B$208M3.7 %
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.

Frequently asked questions

What is Option Care Health's P/E and is the stock undervalued? What's a good P/E?

Option Care Health's P/E is 23.6 (forward 14.9). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Fairly valued".

Is Option Care Health profitable?

Option Care Health has a net margin of 3.7 % (EPS 1.32). The company is profitable.

Is OPCH stock expensive?

Our read: "Fairly valued" — P/E 15 in line with ~13% growth (PEG 1.2). Cross-check with growth and sector.

💬 A question about Option Care Health? The JPI assistant answers using our backtest data.
Keep exploring Option Care Health
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)